Literature DB >> 30503210

Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.

Lilan You1, Jun Ma2, Jiuyu Wang3, Daria Artamonova4, Min Wang5, Liang Liu5, Hua Xiang6, Konstantin Severinov7, Xinzheng Zhang8, Yanli Wang9.   

Abstract

Csm, a type III-A CRISPR-Cas interference complex, is a CRISPR RNA (crRNA)-guided RNase that also possesses target RNA-dependent DNase and cyclic oligoadenylate (cOA) synthetase activities. However, the structural features allowing target RNA-binding-dependent activation of DNA cleavage and cOA generation remain unknown. Here, we report the structure of Csm in complex with crRNA together with structures of cognate or non-cognate target RNA bound Csm complexes. We show that depending on complementarity with the 5' tag of crRNA, the 3' anti-tag region of target RNA binds at two distinct sites of the Csm complex. Importantly, the interaction between the non-complementary anti-tag region of cognate target RNA and Csm1 induces a conformational change at the Csm1 subunit that allosterically activates DNA cleavage and cOA generation. Together, our structural studies provide crucial insights into the mechanistic processes required for crRNA-meditated sequence-specific RNA cleavage, RNA target-dependent non-specific DNA cleavage, and cOA generation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas 9 system; Csm complex; type III-A

Mesh:

Substances:

Year:  2018        PMID: 30503210      PMCID: PMC6935017          DOI: 10.1016/j.cell.2018.10.052

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  45 in total

1.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

2.  Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.

Authors:  Takuo Osawa; Hideko Inanaga; Chikara Sato; Tomoyuki Numata
Journal:  Mol Cell       Date:  2015-04-23       Impact factor: 17.970

3.  Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.

Authors:  Ole Niewoehner; Carmela Garcia-Doval; Jakob T Rostøl; Christian Berk; Frank Schwede; Laurent Bigler; Jonathan Hall; Luciano A Marraffini; Martin Jinek
Journal:  Nature       Date:  2017-07-19       Impact factor: 49.962

4.  Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex.

Authors:  Nancy F Ramia; Michael Spilman; Li Tang; Yaming Shao; Joshua Elmore; Caryn Hale; Alexis Cocozaki; Nilakshee Bhattacharya; Rebecca M Terns; Michael P Terns; Hong Li; Scott M Stagg
Journal:  Cell Rep       Date:  2014-12-04       Impact factor: 9.423

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 6.  An updated evolutionary classification of CRISPR-Cas systems.

Authors:  Kira S Makarova; Yuri I Wolf; Omer S Alkhnbashi; Fabrizio Costa; Shiraz A Shah; Sita J Saunders; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Daniel H Haft; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Rebecca M Terns; Michael P Terns; Malcolm F White; Alexander F Yakunin; Roger A Garrett; John van der Oost; Rolf Backofen; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2015-09-28       Impact factor: 60.633

7.  The genome sequence of the extreme thermophile Thermus thermophilus.

Authors:  Anke Henne; Holger Brüggemann; Carsten Raasch; Arnim Wiezer; Thomas Hartsch; Heiko Liesegang; Andre Johann; Tanja Lienard; Olivia Gohl; Rosa Martinez-Arias; Carsten Jacobi; Vytaute Starkuviene; Silke Schlenczeck; Silke Dencker; Robert Huber; Hans-Peter Klenk; Wilfried Kramer; Rainer Merkl; Gerhard Gottschalk; Hans-Joachim Fritz
Journal:  Nat Biotechnol       Date:  2004-04-04       Impact factor: 54.908

8.  Structural biology. Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning.

Authors:  David W Taylor; Yifan Zhu; Raymond H J Staals; Jack E Kornfeld; Akeo Shinkai; John van der Oost; Eva Nogales; Jennifer A Doudna
Journal:  Science       Date:  2015-04-02       Impact factor: 47.728

9.  Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6.

Authors:  Ole Niewoehner; Martin Jinek
Journal:  RNA       Date:  2016-01-13       Impact factor: 4.942

10.  Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2.

Authors:  Dari Kimanius; Björn O Forsberg; Sjors Hw Scheres; Erik Lindahl
Journal:  Elife       Date:  2016-11-15       Impact factor: 8.140

View more
  37 in total

1.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

2.  Second Messenger cA4 Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release Path.

Authors:  Ning Jia; Roger Jones; George Sukenick; Dinshaw J Patel
Journal:  Mol Cell       Date:  2019-07-17       Impact factor: 17.970

3.  CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA4 Cleavage with ApA>p Formation Terminating RNase Activity.

Authors:  Ning Jia; Roger Jones; Guangli Yang; Ouathek Ouerfelli; Dinshaw J Patel
Journal:  Mol Cell       Date:  2019-07-17       Impact factor: 17.970

4.  A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system.

Authors:  Saifu Pan; Qi Li; Ling Deng; Suping Jiang; Xuexia Jin; Nan Peng; Yunxiang Liang; Qunxin She; Yingjun Li
Journal:  RNA Biol       Date:  2019-05-26       Impact factor: 4.652

5.  Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.

Authors:  Beibei Wang; Tianlong Zhang; Jun Yin; You Yu; Wenhao Xu; Jianping Ding; Dinshaw J Patel; Hui Yang
Journal:  Mol Cell       Date:  2021-01-19       Impact factor: 17.970

Review 6.  Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins.

Authors:  Ning Jia; Dinshaw J Patel
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-04       Impact factor: 94.444

7.  Target sequence requirements of a type III-B CRISPR-Cas immune system.

Authors:  Kaitlin Johnson; Brian A Learn; Michael A Estrella; Scott Bailey
Journal:  J Biol Chem       Date:  2019-05-19       Impact factor: 5.157

8.  Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.

Authors:  Tong Guo; Fan Zheng; Zhifeng Zeng; Yang Yang; Qi Li; Qunxin She; Wenyuan Han
Journal:  RNA Biol       Date:  2019-07-17       Impact factor: 4.652

Review 9.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

10.  Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR-Cas immunity.

Authors:  Kawanda Foster; Sabine Grüschow; Scott Bailey; Malcolm F White; Michael P Terns
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.